In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy

被引:0
|
作者
Tanya Lynn Applegate
Donald John Birkett
Glen John Mcintyre
Angel Belisario Jaramillo
Geoff Symonds
John Michael Murray
机构
[1] Johnson and Johnson Research Pty Ltd,The National Centre in HIV Epidemiology and Clinical Research
[2] Level 4 Biomedical Building,School of Molecular and Microbial Biosciences, School of Biological Sciences
[3] University of New South Wales,School of Mathematics and Statistics
[4] University of Sydney,undefined
[5] Cell and Molecular Therapies,undefined
[6] Faculty of Medicine,undefined
[7] University of New South Wales,undefined
来源
关键词
Gene Therapy; Infected Cell; Chronic Granulomatous Disease; Resistant Virus; Uninfected Cell;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
    Tedbury, Philip R.
    Freed, Eric O.
    FUTURE OF HIV-1 THERAPEUTICS: RESISTANCE IS FUTILE?, 2015, 389 : 171 - 201
  • [42] Prevention of HIV-1 Infection with Antiretroviral Therapy REPLY
    Cohen, Myron S.
    Chen, Ying Q.
    Fleming, Thomas R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20): : 1935 - 1935
  • [43] Gene therapy for HIV-1 infection
    Kohn, DB
    Sarver, N
    ANTIVIRAL CHEMOTHERAPY 4: NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH, 1996, 394 : 421 - 428
  • [44] HIV-1 vectors for gene therapy
    Parolin, C
    Palu, G
    MINERVA BIOTECNOLOGICA, 1997, 9 (03) : 139 - 147
  • [45] Gene therapy as a vaccine for HIV-1
    Berkhout, Ben
    Sanders, Rogier W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1315 - 1321
  • [46] HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Parana Brazil
    Michelon Toledo, Paula Virginia
    de Carvalho, Denise Siqueira
    Romagnoli, Luiza
    Marcinko, Gustavo
    da Cunha, Clovis Arns
    de Souza, Margely Nunes
    Brindeiro, Rodrigo
    de Queiroz-Telles, Flavio
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (04): : 360 - 371
  • [47] Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance
    Grant, Philip M.
    Zolopa, Andrew R.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (08) : 901 - 910
  • [48] Study of HIV-1 Drug Resistance in Patients Receiving Free Antiretroviral Therapy in China
    Xin-ping LI1
    2.State key laboratory for Infectious disease prevention and control
    3.Henan Center for Disease Control and Prevention
    4.Queshan Center for Disease Control and Prevention
    5.Graduate University of Chinese Academy of Sciences
    Virologica Sinica, 2007, (03) : 233 - 240
  • [49] Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy
    Bannister, Wendy P.
    Cozzi-Lepri, Alessandro
    Kjaer, Jesper
    Clotet, Bonaventura
    Lazzarin, Adriano
    Viard, Jean-Paul
    Kronborg, Gitte
    Duiculescu, Dan
    Beniowski, Marek
    Machala, Ladislav
    Phillips, Andrew
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) : 901 - 911
  • [50] Modeling the genetic control of HIV-1 dynamics after highly active antiretroviral therapy
    Ma, Chang-Xing
    Li, Yao
    Wu, Rongling
    CURRENT GENOMICS, 2008, 9 (03) : 208 - 211